Viewing nowProca-van Capsule 25 mg (Pregabalin)
Pregabalin 25mg
Hard capsule · Prescription medication
Eden Pharma Co., Ltd.

MFDS item code 202001648 · Approved 2020.03.10 · Insurance code 628901640
Treatment of neuropathic pain and fibromyalgia; adjunctive treatment of partial-onset seizures in epilepsy
This medication is effective in treating pain caused by peripheral and central neuropathy in adults. It is also used as an adjunctive treatment for partial seizures in epilepsy patients, whether there are secondary generalized symptoms or not. Additionally, it helps alleviate the symptoms of fibromyalgia. It is widely utilized in various neurological disorders and contributes to improving the quality of life of patients.
Administer the total daily dose of this medicine, as pregabalin, orally in 2 divided doses, with or without food. This medicine is excreted primarily by the kidneys; therefore, the dose should be adjusted in patients with renal impairment. (See section ‘5. Patients with renal impairment’.) 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: The initial dose of this medicine may be 150 mg/day. Based on each patient's response and tolerability, the dose may be increased to 300 mg/day after 3 to 7 days. If necessary, the dose may thereafter be increased at 7-day intervals to a maximum of 600 mg/day. 2) Central neuropathic pain Adults: The initial dose of this medicine may be 150 mg/day. Based on each patient's response and tolerability, the dose may be increased to 300 mg/day after 1 week. After an additional week, the dose may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, dose reduction may be considered. (See section ‘4. Discontinuation of administration’.) 2. Epilepsy Adults: The initial dose of this medicine may be 150 mg/day. Based on each patient's response and tolerability, the dose may be increased to 300 mg/day after 1 week. If necessary, the dose may thereafter be increased at 7-day intervals to a maximum of 600 mg/day. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg-450 mg/day. The initial dose is 75 mg twice daily (150 mg/day), and based on efficacy and tolerability, it may be increased within 1 week to 150 mg twice daily (300 mg/day). For patients who do not experience sufficient benefit at a dose of 300 mg/day, the dose may be increased within 1 week to 225 mg twice daily (450 mg/day). Clinical studies have also been conducted at a dose of 600 mg/day; however, there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450 mg/day are not recommended. 4. Discontinuation of administration Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually over at least 1 week. 5. Patients with renal impairment Creatinine clearance [Table 1] is determined using the formula below. Creatinine clearance (mL/min)* = [140 – age (years)] x body weight (kg) 72 x serum creatinine concentration (serum creatinine, mg/dL) * For women, multiply the result obtained from the above equation by 0.85. In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose determined according to renal function, a supplemental dose should be administered promptly after each 4-hour hemodialysis session. [Table 1] Pregabalin dosage based on renal function ≥60: Initial dose 150 (mg/day), maximum dose 600 (mg/day), BID or TID ≥30-<60: Initial dose 75 (mg/day), maximum dose 300 (mg/day), BID or TID ≥15-<30: Initial dose 25-50 (mg/day), maximum dose 150 (mg/day), QD or BID <15: Initial dose 25 (mg/day), maximum dose 75 (mg/day), QD Supplemental dose after hemodialysis: Initial dose 25, maximum dose 100, single dose b TID = Total daily dose divided into 3 doses BID = Total daily dose divided into 2 doses QD = Once daily a: The total daily dose (mg/day) should be divided as specified in the administration schedule. b: A supplemental dose refers to an additional dose administered once. 6. Patients with hepatic impairment No dose adjustment is necessary in patients with hepatic impairment. 8. Older adults (65 years and older) Dose reduction may be necessary in older adults with renal impairment.
Children under 12 years of age: Administration is not recommended because there are insufficient data on safety and efficacy. Adolescent patients aged 12-17 years: Administration is not recommended because there are insufficient data on safety and efficacy.
This medication may increase the risk of suicidal thoughts or behavior, so if there are any changes in mood or behavior during use, patients must inform healthcare professionals immediately. Patients with allergies to the ingredients of this medication or certain genetic disorders should not use it. Diabetic patients should be cautious as weight gain may necessitate adjustments in the dosage of blood sugar control medications. If symptoms of angioedema (swelling of the face or around the mouth) occur, use should be discontinued immediately and medical attention sought. Elderly patients should be careful post-administration due to the risk of dizziness or drowsiness leading to falls or injuries. Some patients may experience blurred vision or changes in vision, and if these symptoms occur, they should consult a healthcare professional. Discontinuing this medication suddenly may lead to withdrawal symptoms such as insomnia, headache, and anxiety, so it should be gradually tapered as directed by a healthcare professional. This medication carries a risk of drug abuse, so patients with a history of substance abuse should be particularly vigilant and monitored for abnormal behavior. Patients with impaired kidney function may require dosage adjustments. Patients with severe cardiac conditions should use this medication with caution. When taken with other medications that have central nervous system depressant effects, there may be an increased risk of drowsiness or respiratory depression, so caution is required. In early pregnancy, there may be a risk of congenital malformations in the fetus, so women who are pregnant or planning to become pregnant should consult with healthcare professionals before use and should use effective contraception. Breastfeeding women should discuss with healthcare professionals whether to discontinue breastfeeding or the medication since it can be passed into breast milk. Activities that require concentration, such as driving or operating machinery, should be avoided until dizziness or drowsiness fully resolves. In the case of overdose, symptoms such as confusion, drowsiness, and seizures may occur, and medical attention should be sought immediately; blood dialysis may be required if necessary. Keep this medication out of the reach of children and avoid transferring it to another container. If severe rashes, swelling, or breathing difficulties occur, use should be stopped immediately and healthcare professionals informed.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture, preferably at room temperature between 15℃ and 30℃. Storing it this way helps maintain the medication's effectiveness for a longer period.
A hard capsule with a light yellow upper part and white lower part containing a white powder.
30 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 25mg
Hard capsule · Prescription medication
Eden Pharma Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.